Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma
- 24 June 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 50 (5), 1453-1463
- https://doi.org/10.1002/hep.23143
Abstract
Our results identify CDH17 as a novel oncogene in HCC and suggest that CDH17 is a biomarker and attractive therapeutic target for this aggressive malignancy.Keywords
This publication has 35 references indexed in Scilit:
- Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and RegenerationCell, 2009
- An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver CancerCell, 2008
- Updates on p53: modulation of p53 degradation as a therapeutic approachBritish Journal of Cancer, 2008
- Restoration of p53 to limit tumor growthCurrent Opinion in Oncology, 2008
- The Prognostic Significance of E-Cadherin and Liver Intestine-Cadherin Expression in Colorectal CancerDiseases of the Colon & Rectum, 2007
- Intestinal LI-cadherin Acts as a Ca2+-dependent Adhesion SwitchJournal of Molecular Biology, 2007
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJCI Insight, 2006
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- Reduced expression of liver–intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinomaCancer Letters, 2004
- Identification of liver–intestine cadherin in hepatocellular carcinoma—a potential disease markerBiochemical and Biophysical Research Communications, 2003